On Invalid Date, Ideaya Biosciences (NASDAQ: IDYA) reported Q4 2023 earnings per share (EPS) of -$0.52, up 3.7% year over year. Total Ideaya Biosciences earnings for the quarter were -$33.96 million. In the same quarter last year, Ideaya Biosciences's earnings per share (EPS) was -$0.54.
As of Q1 2024, Ideaya Biosciences's earnings has grown year over year. Ideaya Biosciences's earnings in the past year totalled -$112.96 million.
What is IDYA's earnings date?
Ideaya Biosciences's earnings date is Invalid Date. Add IDYA to your watchlist to be reminded of IDYA's next earnings announcement.
What was IDYA's revenue last quarter?
On Invalid Date, Ideaya Biosciences (NASDAQ: IDYA) reported Q4 2023 revenue of $3.92 million up 2.49% year over year. In the same quarter last year, Ideaya Biosciences's revenue was $4.02 million.
What was IDYA's revenue growth in the past year?
As of Q1 2024, Ideaya Biosciences's revenue has grown -54.08% year over year. This is 219.7 percentage points lower than the US Biotechnology industry revenue growth rate of 165.61%. Ideaya Biosciences's revenue in the past year totalled $23.39 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.